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Abstract
Purpose : To objectively detect and evaluate vitreous inflammation before and after
dexamethasone implant in patients with uveitis by using a recently developed optical
coherence tomography (OCT)-based algorithm.
Methods :
In this multicenter, retrospective, cross-sectional study, 302 eyes of 223 uveitis patients
were included. Clinical and OCT data (Spectralis; Heidelberg Engineering Inc) of all
patients were collected. The inflammation score was obtained using an available
automated OCT-based algorithm.  Data of pre and post dexamethasone implantation
were compared using a random effects model.
Montesano, G., Way, C. M., Ometto, G., Ibrahim, H., Jones, P. R., Carmichael, R., Liu, X.,
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Results : Patients with cystoid macular edema in uveitis anterior (n=18 eyes),
intermediate (n=106 eyes), posterior (n=153 eyes), and panuveitis (n=25 eyes) were
treated with a dexamethasone implant. The mean of age was 61 years +/- 15 years and a
range of 22 to 88 years. We registered 277 follow-up visits at 1 month (up to 2 months
after injection) and 265 follow-up visits at 3 months (>2 months to 4 months). The mean
inflammation score at baseline was 0.135, and changed significantly to 0.077 (p<0.0001)
1-2 months and to 0.079 (p<0.0001) 3 months after dexamethasone injection.
Correlations with clinical ratings of intraocular inflammation are currently evaluated.
Conclusions : Automated OCT-based objective quantification of vitreous inflammation
captures the expected decrease in vitreous inflammation following intravitreal
dexamethasone implant. Thus, the automated OCT-based quantification of vitreous
inflammation may be a promising alternative and a potentially relevant biomarker
compared to current subjective clinical estimates of vitreous inflammation in uveitis.
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